Research site

Nova-Clin Medical Research Center S.R.L.

Romania Strada Rigoletto 14, 300732 Timisoara, Romania

Influenza · Asthma
Adult patients

About Specializations

Nova-Clin Medical Research Center S.R.L. in Timisoara, Romania specialises in clinical trials of conditions such as Influenza, Asthma, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Research

The Cardiovascular Diseases program at Nova-Clin Medical Research Center focuses on Atherosclerotic Cardiovascular Disease and Chronic Kidney disease, aiming to evaluate new therapeutic options and improve patient outcomes.

Novel cardiovascular drug safety assessments
Kidney‑cardio interaction studies
Biomarker discovery for disease progression

With three investigators leading the effort, the site pursues innovative studies that could shape future standards of care for heart and kidney health in the European region.

Respiratory Research

The Respiratory Tract Diseases portfolio at Nova-Clin Medical Research Center targets moderate to severe controlled asthma, seeking to refine inhaled treatment strategies and reduce airway constriction.

Inhaler propellant performance comparison
Bronchoconstriction safety profiling
Quality‑of‑life assessments for asthma patients

Three dedicated investigators conduct the trials, contributing to the advancement of asthma care across Romania and beyond.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location

Strada Rigoletto 14300732 TimisoaraRomania

Open in maps ↗

Recruiting now: no trials
Conditions studied: 2

More sites in Timisoara Romania

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Quick filters

2 clinical trials

Influenza

Not recruiting

Registered drugNo placebo

Study on the Effectiveness of an MF59-Adjuvanted Influenza Vaccine Compared to a Non-Adjuvanted Vaccine in Adults Aged 65 and Older

Registered drugNo placebo

Romania

Participants:65+ years · Healthy volunteers
Substances:A/DARWIN/9/2021 (H3N2) - LIKE STRAIN (A/DARWIN/6/2021, IVR-227)
Sponsor:Seqirus UK Limited

Contact Research Centre

Asthma

Not recruiting

Registered drugNo placebo

Study on the Safety of CHF5993 Inhaler with HFA-152a vs. HFA-134a in Patients with Moderate to Severe Asthma

Registered drugNo placebo

Romania

Participants:18–64 years · 65+ years
Substances:Salbutamol
Sponsor:Chiesi Farmaceutici S.p.A.

Contact Research Centre

Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites